Chembio Diagnostics DIO Ratio 2011-2026 | CEMI

Annual DIO Ratio Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
97.6	135	169	142	99.1	110	129	94.9	78.9	67.5	61.3	84	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
169	61.3	106

Quarterly DIO Ratio Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	93.4	131	74.2	-	188	343	350	-	162	202	214	-	120	129	169	-	83	93.4	105	-	115	181	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
350	74.2	162

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	137	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	7.17	$ 19.5	7.5 %	$ 600 M	USA
Co-Diagnostics CODX	1.69 K	$ 5.76	11.41 %	$ 7.66 M	USA
Castle Biosciences CSTL	47.2	$ 21.6	5.93 %	$ 626 M	USA
Aspira Women's Health AWH	32.2	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Guardant Health GH	82.1	$ 133.06	4.75 %	$ 16.7 B	USA
Biocept BIOC	21.9	-	-13.05 %	$ 7.29 M	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
ICON Public Limited Company ICLR	0.213	$ 152.8	6.18 %	$ 12 B	Irlanda
CareDx, Inc CDNA	48.3	$ 23.12	3.63 %	$ 1.23 B	USA
Illumina ILMN	138	$ 168.06	-1.68 %	$ 26 B	USA
Interpace Biosciences IDXG	29.1	$ 1.79	2.29 %	$ 7.92 M	USA
HTG Molecular Diagnostics HTGM	116	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
Mettler-Toledo International MTD	79	-	-	$ 24.3 B	Schweiz
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	40.4	-	-	$ 6.94 B	USA
NeoGenomics NEO	24.4	$ 11.31	11.54 %	$ 1.45 B	USA
Charles River Laboratories International CRL	35.3	$ 185.79	3.29 %	$ 9.21 B	USA
Natera NTRA	25.8	$ 222.1	4.84 %	$ 30.4 B	USA
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	42.8	$ 4.69	6.59 %	$ 434 M	USA
Personalis PSNL	12.1	$ 12.1	12.24 %	$ 1.08 B	USA
Koninklijke Philips N.V. PHG	89	$ 25.99	2.52 %	$ 24.6 B	Niderland
Senseonics Holdings SENS	104	$ 7.01	4.32 %	$ 293 M	USA
QIAGEN N.V. QGEN	141	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	1.02 K	-	-	$ 2.69 B	USA
Biomerica BMRA	147	-	-	$ 4.94 M	USA
Laboratory Corporation of America Holdings LH	18.9	$ 260.97	0.79 %	$ 21.7 B	USA
Twist Bioscience Corporation TWST	51.5	-	-	$ 4.42 B	USA
Thermo Fisher Scientific TMO	86.5	$ 482.03	1.7 %	$ 182 B	USA
Trinity Biotech plc TRIB	212	$ 0.68	-2.4 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	3.37 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	147	$ 9.12	3.52 %	$ 1.98 B	USA
Quest Diagnostics Incorporated DGX	9.34	$ 196.12	1.27 %	$ 21.8 B	USA
Invitae Corporation NVTA	126	-	-	$ 21.2 M	USA
Waters Corporation WAT	528	$ 376.47	-0.87 %	$ 22.4 B	USA